Cipla reported INR11.43B in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Cipla CIPLA:IN IR 11433.5M 3936.3M
Dr.Reddys Laboratories DRRD:IN IR 9412M 2517M
Sun Pharmaceuticals SUNP:IN IR 27387.2M 5593.7M
UPL UPLL:IN IR 23430M 12490M